# Bavarian Nordic awarded $100M smallpox vaccine contract by U.S. government

Bavarian Nordic secured a sole source contract from BARDA for freeze-dried IMVAMUNE smallpox vaccine, with an initial base award of USD 100 million for bulk manufacturing and potential total value exceeding USD 539 million.

- Type: Contract
- Announced: 2017-09-27
- Where: United States
- Value: $100.0M
- Status: announced
- Products: freeze-dried IMVAMUNE smallpox vaccine

## Companies

- [Bavarian Nordic](https://endata.com/companies/26366.md)
- [BARDA](https://endata.com/companies/8812.md) (customer)

## Sources

- [biospace.com](https://www.biospace.com/bavarian-nordic-secures-contract-award-for-supply-of-freeze-dried-imvamune-smallpox-vaccine-to-the-u-s-government), 2017-09-28: "The initial award in the contract calls for the manufacturing and storage of USD 100 million of IMVAMUNE bulk."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.